Certa Dose, Inc.

CourtUnited States Bankruptcy Court, S.D. New York
DecidedNovember 4, 2021
Docket21-11045
StatusUnknown

This text of Certa Dose, Inc. (Certa Dose, Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Certa Dose, Inc., (N.Y. 2021).

Opinion

UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF NEW YORK ---------------------------------------------------------------x In re: : : Certa Dose, Inc., : Chapter 11 : Case No. 21-11045 (LGB) Debtor. : ---------------------------------------------------------------x

DECISION ON MOTION OF COPIC INSURANCE COMPANY, PURSUANT TO 28 U.S.C. § 1412 AND FED. R. BANKR. P. 1014(A)(2), TO TRANSFER VENUE TO THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF COLORADO

A P P E A R A N C E S

ORTIZ & ORTIZ LLP Attorneys for the Debtor 35-10 Broadway, Suite 202 Astoria, NY 11060 By: Norma E. Ortiz, Esq.

LEWIS ROCA ROTHGERBER CHRISTIE LLP Attorneys for COPIC Insurance Company 1630 Welton Street, Suite 200A Denver, CO 80202 By: Fredrick J. Baumann, Esq. Chadwick S. Caby, Esq. Tyler Nemkov, Esq.

MEDINA LAW FIRM LLC Attorneys for Dr. Caleb Hernandez 641 Lexington Avenue, 13th Floor New York, NY 10022 By: Eric S. Medina, Esq. LISA G. BECKERMAN UNITED STATES BANKRUPTCY JUDGE The Court denies the Motion of COPIC Insurance Company, Pursuant to 28 U.S.C. § 1412 and Fed. R. Bankr. P. 1014(a)(2), to Transfer Venue to the United States Bankruptcy Court for the District of Colorado [ECF No. 36] (the “Motion”) because the preponderance of the evidence does not support a transfer of venue of the Chapter 11 case from the United States Bankruptcy Court for the Southern District of New York to United States Bankruptcy Court for the District of Colorado either in the interest of justice or for the convenience of parties. I. PROCEDURAL BACKROUND AND FINDINGS OF FACT On May 30, 2021 (the “Petition Date”), Certa Dose, Inc. (the “Debtor”) filed a voluntary petition under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York commencing this Chapter 11 case (the “Case”). On June 22, 2021, COPIC Insurance Company (“COPIC” or the “Movant”) filed the Motion. The Motion requests that this Court to transfer venue of the Case from the United States Bankruptcy Court for the Southern District of New York to the United States Bankruptcy Court for the District of Colorado. The Motion is joined by the following parties: Stephen R. Hoffenberg (“Dr. Hoffenberg”); Alan Young Synn; Davis K. Hurley; Brian C. Harrington; Niles Cole; Geraldine A. Lewis-Jenkins; Matthew Fleishman; Theodore J. Clarke; Katherine Driscoll, as Trustee of the 2015 LFD III GRAT-TRUST U/A 8.26.15; Phoebe Fisher, M.D.; Thomas S. Cowan; and Anthony R. Mayer (collectively, the “Noteholders”). Motion pp. 4-5. On July 9, 2021, the Debtor filed an opposition to the Motion [ECF No. 56] (the “Objection”) and Dr. Caleb Hernandez (“Dr. Hernandez”), founder, chief executive officer, and the majority shareholder of the Debtor, filed a joinder to the Debtor’s Objection [ECF No. 55]. On July 12, 2021, COPIC filed a reply in support of the Motion [ECF No. 62] (the “Reply”). Counsel to COPIC filed the following declarations in support of the Motion: (i) on June 22, 2021, declarations of Steve Rubin and Chad S. Caby, Motion Exs. 1–2; (ii) on July 12, 2021, declarations of each of the Noteholders and Daniel Hoffman, Reply Exs. 3–15; and (iii) on August 10, 2021, a supplemental declaration of Dr. Hoffenberg [ECF No. 86]. Counsel to the Debtor filed the following declarations in opposition to the Motion: (i) on July 9, 2021, a declaration of Dr. Hernandez [ECF No. 54] (the “Hernandez Venue Decl.”) and declarations of Daniel Eason, Andrew Glaser, and Robert Willoughby, III, Hernandez Venue Decl. Ex. A; (ii) on July 23, 2021, a first supplemental declaration of Dr. Hernandez [ECF No. 71] (the “First Suppl. Hernandez Venue Decl.”); and (iii) on September 28, 2021, a second supplemental declaration, which contained modifications to a declaration filed on September 17, 2021 [ECF No. 119] (the “Second Suppl. Hernandez Venue Decl.”). This Court held a four-day evidentiary hearing on the Motion on September 21, 22, 23, and 28, 2021 wherein 134 exhibits, including the various declarations, were moved by the parties and entered into evidence as part of the hearing record. A. The Debtor and Its Operations The Debtor was founded by Dr. Hernandez in 2013 and originated in Colorado. Hernandez Venue Decl. ¶¶ 3–4. The Debtor was incorporated in the state of Delaware. Id. at ¶ 4. The Debtor is primarily in the business of developing specifications and licensing patents for medical devices including syringes and kits used to deliver medicine to in a manner that reduces the risk of overdose or to deliver epinephrine. Id. at ¶ 3. The Debtor is a specifications developer and does not manufacture its own products. Rather, the Debtor’s function is to engineer and design its products, and to administer and monetize the intellectual property that it develops. Transcript of Evidentiary Hearing on September 28, 2021 (“Sept. 28 Tr.”) at 28:14– 22. Based on Dr. Hernandez’s testimony, the Debtor presently contracts with two vendors for the manufacture of its products: SMC Ltd. and PlasTech Engineering. Id. at 29:2–6; First Suppl. Hernandez Venue Decl. ¶ 16. The Debtor contracts with these vendors in order to procure products ordered by the Debtor’s distributors. Sept. 28 Tr. at 29:2–30:30. Cardinal Health, a third-party logistics company, receives and ships the Debtor’s products intended for distributors and accepts payment from the distributors which it then remits to the Debtor. Id.; First Suppl. Hernandez Venue Decl. ¶ 16. The Debtor generates most of its revenue from its licensing business, whereby it licenses patents to pharmaceutical manufacturers. Sept. 28 Tr. at 34:3–11. Sources of revenue from this area of the Debtor’s business include the Debtor’s collaboration agreement with Johnson & Johnson Consumer, Inc. (“J&J”), COPIC Ex. 66, and its collaboration agreement with Janssen Pharmaceuticals, Inc. (“Janssen”), COPIC Ex. 13, among other agreements. The Debtor is registered to do business in Colorado, Delaware, and New York. Second Suppl. Hernandez Venue Decl. ¶ 6. B. Events Leading up to the Chapter 11 Filing 1. Investments by COPIC and the Noteholders into the Debtor COPIC is a medical professional liability insurance provider founded in 1981 by Colorado physicians and is incorporated and headquartered in Colorado. Motion Ex. 1 (the “Rubin Decl.”), ¶¶ 2–3. In 2012, the COPIC Medical Foundation provided a grant to Dr. Hernandez that funded field testing of certain medical products. Id. at ¶ 5. Subsequently, from December 2014 to March 2019, through a series of transactions, COPIC purchased 483,824 shares of Series Seed 2 Preferred Stock of the Debtor (“Preferred Stock”) for a total of $850,000 and lent a total of $2,231,000 to the Debtor in exchange for convertible promissory notes (“Convertible Notes”). Id. at ¶¶ 6–13. From January 2015 to late 2018, Dr. Hoffenberg served as COPIC’s designee member of the Debtor’s board of directors. Transcript of Evidentiary Hearing on September 22, 2021 (“Sept. 22 Tr.”) at 187:9–12.1 Thereafter, for approximately eleven months ending in October 2019, Mr. Rubin, the president of COPIC, served as COPIC’s designee on the Debtor’s board. Transcript of Evidentiary Hearing on September 21, 2021 (“Sept. 21 Tr.”) at 180:19–25.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Enron Corp. v. Arora (In Re Enron Corp.)
317 B.R. 629 (S.D. New York, 2004)
In Re Enron Corp.
274 B.R. 327 (S.D. New York, 2002)
In Re International Filter Corp.
33 B.R. 952 (S.D. New York, 1983)
In Re Enron Corp.
284 B.R. 376 (S.D. New York, 2002)
In Re Eclair Bakery Ltd.
255 B.R. 121 (S.D. New York, 2000)
In Re Greenhaven Associates, Ltd.
93 B.R. 35 (S.D. New York, 1988)
Rescap Liquidating Trust v. PHH Mortgage Corp.
518 B.R. 259 (S.D. New York, 2014)
ICICI Bank Ltd. v. Essar Global Fund Ltd.
565 B.R. 241 (S.D. New York, 2017)
In re Patriot Coal Corp.
482 B.R. 718 (S.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Certa Dose, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/certa-dose-inc-nysb-2021.